| Financial Year |
March 31 2023 |
| Monetary Funds |
80,342,723.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
28,216,401.95 |
| Advances to Suppliers |
9,187,320.02 |
| Other Receivables |
392,466,876.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
305,200.00 |
| Inventories |
16,739,295.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,729,358.10 |
| Total Current Assets |
540,933,125.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
123,693,584.93 |
| Investment Properties |
10,029,694.91 |
| Fixed Assetes |
1,753,094,020.16 |
| Under-construction Projects |
79,076,664.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
292,502,892.95 |
| R&D expenses |
-- |
| Goodwill |
42,345,610.17 |
| Long-Term Deferred and Prepaid Expenses |
1,162,185.82 |
| Deferred Income Tax Assets |
39,672,297.93 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,341,576,950.87 |
| Total Assets |
2,882,510,076.32 |
| Short-Term Loans |
755,082,955.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,576,772.12 |
| Accounts Payable |
132,226,716.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,231,330.42 |
| Taxes Payable |
51,048,882.77 |
| Interest Payable |
88,252,979.39 |
| Dividend Payable |
7,312,477.24 |
| Other payables |
208,849,285.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
129,260,473.96 |
| Other Current Liabilities |
24,428,935.94 |
| Sub-Total of Current Liabilities |
1,499,836,870.53 |
| Long-term Loans |
218,700,000.00 |
| Bonds Payable |
173,631,040.00 |
| Long-Term Accounts Payable |
48,537,811.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
343,265,327.19 |
| Deferred Income Tax Liabilities |
6,314,469.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
798,517,621.41 |
| Total Liabilities |
2,298,354,491.94 |
| Paid-In Capital(Or Share Stock) |
680,408,797.00 |
| Capital Surplus |
1,618,391,548.32 |
| Surplus Reserve |
112,452,706.05 |
| LESS:Treasury Stock |
75.68 |
| Undistributed Profits |
-1,955,325,869.72 |
| Minority Stockholder's Interest |
126,312,250.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
457,843,334.03 |
| Owner's Equity（Stockholder's Equity） |
584,155,584.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,882,510,076.32 |
